Alzheimer's
Alzheimer’s disease research draws on a broad range of reference standards spanning cholinesterase inhibitors like donepezil, NMDA receptor modulators, dopamine and opioid receptor ligands, and natural compounds studied for neuroprotective activity. These standards support drug discovery targeting cognitive decline, receptor binding and enzyme inhibition assays, and structure-activity relationship studies across multiple neurotransmitter systems relevant to the disease. Sourcing from a dedicated supplier means every compound, from an established cholinesterase inhibitor to a less common receptor ligand, arrives with verified identity, documented purity, and a certificate of analysis.
Showing 1–16 of 1435 results
-
?-Aminobutyric Acid
CAS Number: 02-12-1956
Molecular Formula: C4 H9 N O2
Catalogue Number: RCLS2L103966
-
(-)-2Beta-Carbomethoxy-3Beta-(4-iodophenyl)nortropane
CAS Number: 136794-87-1
Molecular Formula: C15 H18 I N O2
Catalogue Number: RCLS2L118291
-
![(-)-3,4,4a,5,6,10b-Hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol, Hydrochloride](https://www.clinivex.com/wp-content/uploads/watermarked/271605-full.jpg?v=1788806310)
(-)-3,4,4a,5,6,10b-Hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol, Hydrochloride
CAS Number: 1322623-41-5
Molecular Formula: C12 H15 N O2 . HCl
Catalogue Number: RCLS2L148821
-
(-)-Alpha-Kainic Acid Lithium Salt
CAS Number: N/A
Molecular Formula: C10 H14 Li N O4
Catalogue Number: RCLS2L155960
-
(-)-Coclaurine Hydrochloride
CAS Number: 3422-42-2
Molecular Formula: C17H20ClNO3
Catalogue Number: RCLS2L123980
-
-
-
(-)-Epigallocatechin Gallate-d3/d4
CAS Number: N/A
Molecular Formula: C22 D3 H15 O11
Catalogue Number: RCLS2L140673
-
(-)-Eseroline Fumarate Salt
CAS Number: 70310-73-5
Molecular Formula: C13H18N2O . (C4H4O4)
Catalogue Number: RCLS2L141754
-
-
-
(-)-MK 801 Maleate
CAS Number: 121917-57-5
Molecular Formula: C16H15N . C4H4O4
Catalogue Number: RCLS2L165661
-
(-)-Nefopam Hydrochloride
CAS Number: 53625-25-5
Molecular Formula: C17H19NO . HCl
Catalogue Number: RCLS2L167974
-
-
(-)-Quinpirole Hydrochloride
CAS Number: 85798-08-9
Molecular Formula: C13H21N3 . (HCl)
Catalogue Number: RCLS2L177059
-
(-)-Valerenic Acid
CAS Number: 06-10-3569
Molecular Formula: C15 H22 O2
Catalogue Number: RCLS2L186353
Reference Standards Supporting Alzheimer’s Disease Research
Reliable standards matter throughout Alzheimer’s research, where multiple neurotransmitter systems, cholinergic, dopaminergic, and glutamatergic, are often studied together to understand disease progression and potential treatments. With over a thousand compounds relevant to this field, a single certified source considerably simplifies sourcing.
Clinivex supplies an extensive range of Alzheimer’s-related reference standards, each backed by a certificate of analysis. Our technical team can help identify the right compound, metabolite, or labeled variant for your specific study, drawing on our global supplier network when needed.
As an ISO 9001:2015 and GMP certified supplier working with laboratories and pharmaceutical researchers across the USA and Canada, we focus on accurate documentation and dependable delivery, regardless of order size.
Cholinesterase inhibitors relevant to this research overlap closely with the acetylcholinesterase standards covered elsewhere in our catalogue. Broader CNS drug development work is a recurring subject within pharmaceutical and biotech research.
Contact our team to request a quote or check availability for a specific Alzheimer’s-related standard.
why Choose Clinivex?
At Clinivex, we earn trust by delivering impeccable service, expert guidance, and reliable solutions that drive long-term success. With a skilled team and customer-first approach, we stand as a leading pharmaceutical reference standards supplier in the USA and Canada.
Dedicated Towards Betterment
Driven by innovation, committed to progress.
One-Stop Product Source
All-in-one destination for trusted scientific solutions.
Where Trust Meets Innovation
Blending trust, accuracy, and innovation for groundbreaking results.
Fast and Courteous Customer Service
Merging reliability, accuracy, and innovation to redefine excellence.
Have questions? Get in touch!
Just fill in your details and our representatives will get back to you soon!
Frequently Asked Questions
The disease affects several neurotransmitter pathways at once, so researchers frequently study cholinergic, glutamatergic, and dopaminergic compounds together to build a fuller picture of disease mechanisms.
It’s the theory that a decline in acetylcholine signaling contributes to the memory and cognitive symptoms of Alzheimer’s disease, which is why cholinesterase inhibitors remain a common treatment approach.
Yes. Several plant-derived compounds are studied for neuroprotective or cognitive-supporting properties alongside conventional pharmaceutical candidates.
Join other members of the R&D community getting the latest news, information and guides.